Citation: | SHEN Su, ZHAO Shi-xian, REN Qing-ling. Microbiota and Metabolomics Study of Vaginal Lavage Fluid in Patients with Persistent HR-HPV Infection with Dampness-Heat Syndrome[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(4): 485-490. doi: 10.14148/j.issn.1672-0482.2021.0485 |
[1] |
马丁. 精准医疗在宫颈癌防治中的应用[J]. 实用妇产科杂志, 2017, 33(6): 403-406. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201706004.htm
|
[2] |
FITZMAURICE C. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study[J]. J Clin Oncol, 2018, 36(S15): 1568.
|
[3] |
HU SY, REZHAKE R, CHEN F, et al. Outcomes in women with biopsy-confirmed cervical intraepithelial neoplasia grade 1 or normal cervix and related cofactors: A 15-year population-based cohort study from China[J]. Gynecol Oncol, 2020, 156(3): 616-623. doi: 10.1016/j.ygyno.2019.12.027
|
[4] |
傅山. 傅青主女科[M]. 4卷. 上海: 上海科学技术出版社, 1957: 12.
|
[5] |
薛已. 女科撮要[M]. 北京: 人民卫生出版社, 1983: 492.
|
[6] |
朱若熙, 郝敏, 赵卫红, 等. 阴道微生物代谢产物及酶改变与高危型人乳头瘤病毒感染和宫颈上皮内瘤变发生风险的关系[J]. 中国实用妇科与产科杂志, 2019, 35(7): 797-802. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201907019.htm
|
[7] |
CHAMPER M, WONG AM, CHAMPER J, et al. The role of the vaginal microbiome in gynaecological cancer[J]. BJOG, 2018, 125(3): 309-315. doi: 10.1111/1471-0528.14631
|
[8] |
DAHOUD W, MICHAEL CW, GOKOZAN H, et al. Association of bacterial vaginosis and human Papilloma virus infection with cervical squamous intraepithelial lesions[J]. Am J Clin Pathol, 2019, 152(2): 185-189. doi: 10.1093/ajcp/aqz021
|
[9] |
叶银利, 桑晓庆, 熊翡, 等. 宫颈HPV感染患者的体质与中医证型分析[J]. 浙江中医杂志, 2016, 51(3): 168-169. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJZZ201603010.htm
|
[10] |
魏丽惠, 赵昀, 沈丹华, 等. 中国子宫颈癌筛查及异常管理相关问题专家共识(一)[J]. 中国妇产科临床杂志, 2017, 18(2): 190-192. https://www.cnki.com.cn/Article/CJFDTOTAL-FKLC201702034.htm
|
[11] |
魏丽惠, 沈丹华, 赵方辉, 等. 中国子宫颈癌筛查及异常管理相关问题专家共识(二)[J]. 中国妇产科临床杂志, 2017, 18(3): 286-288. https://www.cnki.com.cn/Article/CJFDTOTAL-FKLC201703043.htm
|
[12] |
WEN CY, LI FN, ZHANG LY, et al. Taurine is involved in energy metabolism in muscles, adipose tissue, and the liver[J]. Mol Nutr Food Res, 2019, 63(2): 1800536. doi: 10.1002/mnfr.201800536
|
[13] |
SCHULLER-LEVIS GB, PARK E. Taurine and its chloramine: Modulators of immunity[J]. Neurochem Res, 2004, 29(1): 117-126. doi: 10.1023/B:NERE.0000010440.37629.17
|
[14] |
STACY A, ANDRADE-OLIVEIRA V, MCCULLOCH JA, et al. Infection trains the host for microbiota-enhanced resistance to pathogens[J]. Cell, 2021, 184(3): 615-627. http://www.ncbi.nlm.nih.gov/pubmed/33453153
|
[15] |
ZIZZO MG, MULE F, MASTROPAOLO M, et al. Can guanine-based purines be considered modulators of intestinal motility in rodents?[J]. Eur J Pharmacol, 2011, 650(1): 350-355. http://www.onacademic.com/detail/journal_1000035042311510_c651.html
|
[16] |
VISNES T, CSZARES-KORNER A, HAO W, et al. Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation[J]. Science, 2018, 362(6416): 834-839. doi: 10.1126/science.aar8048
|
[17] |
GIORDANO C, KARASIK O, KING-MORRIS K, et al. Uric acid as a marker of kidney disease: Review of the current literature[J]. Dis Markers, 2015, 2015: 382918. http://downloads.hindawi.com/journals/dm/2015/382918.pdf
|
[18] |
NG G, CHAU EM, SHI Y. Recent developments in immune activation by uric acid crystals[J]. Arch Immunol Ther Exp, 2010, 58(4): 273-277. doi: 10.1007/s00005-010-0082-1
|